Where does Janssen Sciences Ireland UC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Janssen Sciences Ireland UC ranks #3,349 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Janssen Sciences Ireland UC hold?

Janssen Sciences Ireland UC holds 111 US utility patents granted between 2015 and 2024, spanning 10 technology areas.

What is Janssen Sciences Ireland UC's Innovation Score?

Janssen Sciences Ireland UC has an Innovation Score of 35.6 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Janssen Sciences Ireland UC's patent grant rate increasing or decreasing?

Janssen Sciences Ireland UC's recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Janssen Sciences Ireland UC's patents?

Janssen Sciences Ireland UC's patents average 12.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Janssen Sciences Ireland UC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Janssen Sciences Ireland UC

Q: What technology areas does Janssen Sciences Ireland UC focus on?

Janssen Sciences Ireland UC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 108 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 111 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Janssen ranks #3,349 of 49,997 tracked US assignees by granted-patent volume, with 111 patents across 10 technology areas.

#3,349
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.6/100): 12.5
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3349 · Foreign Corporation #3,349 · 111 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 111 grants
TOP-DECILE #3,349/49,997
PHOTO-FINISH Global Life…
CPC-FOCUS A61P · 10 areas
INNOV-THIN 35.6/100
CLAIMS-RICH 12.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Global Life Sciences Solutions USA LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cameron Health · near

36
Hettich-ONI & KG · near

36
CommScope Asia… · near

36
Janssen Sciences… · this assignee

36
Nomis · near

36
3D Lighting… · lowest

7

What this shows Janssen's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Janssen's grants concentrate

Janssen Sciences Ireland UC is a focused PatentsView assignee: 10 CPC subclasses with 97.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (24 grants) versus a trough of 1 in 2024. By volume, Janssen sits between Global Life Sciences Solutions USA LLC and MillerKnoll, Inc..

Janssen's three-year grant acceleration

From 2019–2021 to 2022–2024, Janssen Sciences Ireland UC moved from 30 to 3 grants (0.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,176. See the growth leaderboard.

Global Life Scien…

111
Goldman Sachs &

111
Hongqisheng Preci…

111
Imperial Innovati…

111
Kulicke and Soffa…

111
Macneil IP

111
Musc Foundation f…

111
Millerknoll

111
Janssen Sciences… ◀

111

What this shows Janssen holds 111 patents at rank #3,349, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Janssen

By rank, the assignees closest to #3,349 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Janssen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Janssen, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Nomis LLC 36 CommScope Asia Holdings B.V. 36 Cameron Health, Inc. 36 Hettich-ONI GmbH & Co. KG 36

Similar claim depth

Nearest assignees by average claims per patent (12.5 here).

Liberty Hardware MFG. Corp. 12.5 avg Glory Ltd. 12.5 avg Vitesco Technologies GMBH 12.5 avg KX Technologies LLC 12.5 avg

Janssen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Janssen Sciences Ireland UC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	9.0%
2016	24	21.6%
2017	20	18.0%
2018	24	21.6%
2019	16	14.4%
2020	9	8.1%
2021	5	4.5%
2023	2	1.8%
2024	1	0.9%

Which technologies does Janssen Sciences Ireland UC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 108

C07D - Heterocyclic Compounds 91

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 75

Y02A - Technologies FOR Adaptation TO Climate Change 12

C07K - Peptides 7

C07C - Acyclic OR Carbocyclic Compounds 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#3,349

of 49,997 tracked assignees

Innovation Score

35.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Janssen Sciences Ireland UC's patent record in context - here's where to go next.

Janssen Sciences Ireland UC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 97.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,349 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Janssen Sciences Ireland UC against Global Life Sciences Solutions USA LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.